Project to improve care for First Nations cancer patients News article
Palliative care and First Nations professionals from the RMH and the Peter MacCallum Cancer Centre are looking to improve cancer care and treatment for Aboriginal and/or Torres Strait Islander patients.
https://www.thermh.org.au/news/project-to-improve-care-for-first-nations-cancer-patientsThe RMH researchers receive more than $17 million in grants from NHMRC News article
The Royal Melbourne Hospital (RMH) researchers have received $17,480,419 in funding from the latest round of the National Health and Medical Research Council’s (NHMRC) grant announcements this week.
https://www.thermh.org.au/news/the-rmh-researchers-receive-more-than-17-million-in-grants-from-nhmrcGenetic Medicine RMH Service
We provide multidisciplinary clinical services including cardiac, immunological, neurogenetics, endocrine, and a full range of other non-cancer genetic conditions.
https://www.thermh.org.au/services/genetic-medicineIf you're feeling more down, sad or miserable than you have in the past, and those feelings start to get in the way of your life, it might be time to get help.
https://www.thermh.org.au/services/mental-health/learn-about/experiencing-mental-health-challenges/feeling-depressedExternal grant funding providers
Our A to Z list of organisations that provide funding for medical research.
https://www.thermh.org.au/research/office-for-research/research-endeavours/grant-application-management/external-grant-funding-providersNew study finds thrombectomy benefits patients with large ischaemic strokes News article
A recent study has shown that endovascular thrombectomy, a minimally invasive procedure that removes blood clots, can improve the outcomes of patients with large ischaemic strokes.
https://www.thermh.org.au/news/new-study-finds-thrombectomy-benefits-patients-with-large-ischemic-strokesNew drug for basal cell carcinoma Research study
A study to assess the safety and efficacy of ASN-002 combined with a hedgehog pathway inhibitor (vismodegib) in the treatment of multiple low-risk basal cell carcinomas in sporadic or basal cell naevus syndrome patients.
https://www.thermh.org.au/research/clinical-trials-research-studies/new-drug-for-basal-cell-carcinomaWe can provide you with permission and advice on correctly using the Royal Melbourne Hospital (RMH) brand.
https://www.thermh.org.au/news/media-hub/brand-requestsEffects of denosumab on normal breast tissue for BRCA gene carriers Research study
A trial to investigate the effects of denosumab on normal breast tissue in patients with BRCA 1 or 2 mutations and to determine if the drug has the potential to prevent breast cancer.
https://www.thermh.org.au/research/clinical-trials-research-studies/effects-of-denosumab-on-normal-breast-tissue-for-brca-gene-carriersStaying well and preventing relapse
We have relapse-prevention strategies, wellness and recovery plans, advance care planning, self-care and early warning signs to help you stay well.
https://www.thermh.org.au/services/mental-health/learn-about/staying-well-preventing-relapseLearn more about holiday dialysis options if you are one of our patients and are planning a trip away from Melbourne, or an Australian or overseas traveller visiting Melbourne.
https://www.thermh.org.au/services/kidney-care/learn-about/holiday-dialysisProfessor Andrew Roberts named in the Ramaciotti Awards for Biomedical Research News article
The 2020 Ramaciotti Awards for Biomedical Research have been announced, with Professor Andrew Roberts being named the joint winner of the Ramaciotti Medal for Excellence.
https://www.thermh.org.au/news/professor-andrew-roberts-named-in-the-ramaciotti-awards-for-biomedical-researchRemote monitoring device trial underway at the RMH News article
A new contactless device that can detect and record patients’ vital signs is being trialled in the Acute Care of Elderly (ACE) ward at the Royal Melbourne Hospital (RMH).
https://www.thermh.org.au/news/remote-monitoring-device-trial-underway-at-the-rmhSpecialist Outreach Clinics RMH Service
We run specialist outreach clinics in rural, regional and urban primary care centres to enable provision of tertiary services for refugees and other patients in the community.
https://www.thermh.org.au/services/victorian-infectious-diseases-service/vids-services/refugee-health/specialist-outreach-clinicsSeladelpar as a treatment for primary biliary cholangitis (PBC) Research study
A study to evaluate the safety and effectiveness of an investigational drug, seladelpar, in treating patients with primary biliary cholangitis (PBC).
https://www.thermh.org.au/research/clinical-trials-research-studies/seladelpar-as-a-treatment-for-primary-biliary-cholangitis-pbcNew drug for moderate to severe hidradenitis suppurativa Research study
A clinical trial to assess the safety and effectiveness of a new drug for hidradenitis suppurativa.
https://www.thermh.org.au/research/clinical-trials-research-studies/new-drug-for-moderate-to-severe-hidradenitis-suppurativaThe Physiotherapy and Exercise Physiology Department has an active clinical research program.
https://www.thermh.org.au/services/physiotherapy-exercise-physiology/physiotherapy-researchNeuropsychologist receives Post-Doctoral Fellowship to advance MS research News article
Dr Charles Malpas aims to address the gap in knowledge on the variants of cognitive impairment among Multiple Sclerosis (MS) patients with a substantial MS Research Australia grant.
https://www.thermh.org.au/news/the-rmh-neuropsychologist-receives-165000-post-doctoral-fellowship-to-advance-ms-researchCardiothoracic Unit celebrates 40 years at the RMH News article
Happy (kind-of!) 40th anniversary to the Cardiothoracic Unit!
https://www.thermh.org.au/news/cardiothoracic-unit-celebrates-40-years-at-the-rmhTirzepatide for people with type 2 diabetes Research study
A clinical trial investigating the safety and effectiveness of tirzepatide taken once weekly compared to insulin taken once daily in people with type 2 diabetes and increased cardiovascular risk.
https://www.thermh.org.au/research/clinical-trials-research-studies/tirzepatide-for-people-with-type-2-diabetes